Bioequivalence Study of Synflutide HFA Inhaler and Seretide Evohaler in Healthy Volunteers Without Charcoal Block
Status:
Completed
Trial end date:
2014-08-01
Target enrollment:
Participant gender:
Summary
The objective of this pivotal study is to evaluate the relative bioavailability of Synflutide
HFA 250/25 Inhaler and SeretideTM 250 EvohalerTM in healthy volunteers without charcoal
block.